Our deep resources and industry knowledge make us the ideal partner to scientists and entrepreneurs worldwide.

넳 넲

Arctic Vision Announced Positive Topline Results of Phase III Clinical Trial of Suprachoroidal Space Injection Therapy ARVN001 for Uveitic Macular Edema Patients in China

넶2 2024-11-01
Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs

넶3 2024-11-01
SanReno Therapeutics Announces Acquisition by Novartis in Pivotal Transaction to Bring Forward Transformative Therapeutics in Kidney Disease

넶2 2024-11-01
Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb

넶1 2024-11-01
与诺华“联姻”后，Chinook又携两项核心资产“炸场”ERA年会

넶1 2024-11-01
神领锐医药宣布与台湾晶实公司签署独家经销协议

넶3 2024-11-01
合凯维生命科学首次亮相，完成近千万美元的种子轮融资，进军全球女性健康市场

넶3 2024-11-01
2022 ASN肾脏周披露最新数据 | BION-1301治疗显著降低IgA肾病患者尿蛋白水平

넶3 2024-11-01
Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics

넶2 2024-11-01
Arctic Vision Announces First Patient Enrolled in Phase III Clinical Trialof ARVN002 for Progressive Myopia This marks yet another successful expansion of Arctic Vison's MAP™ technology

넶2 2024-11-01

SHANGHAI

Suite 1203-04, Tower 2
Century Link, No.1196 Century Avenue
Pudong District
Shanghai 200122, China

SAN FRANCISCO

501 2nd Street, Suite 200 San Francisco, CA 94107 United States

HONG KONG

17th Floor

AIRSIDE

2 Concorde Road, Kai Tak

Hong Kong SAR

PRIVACY POLICY

TERMS AND CONDITIONS

1

© 2024 Pivotal Life Sciences- All intellectual property rights reserved